Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.72 USD
Change Today -0.13 / -1.32%
Volume 31.3K
AGRX On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 07/30/15 All times are local (Market data is delayed by at least 15 minutes).

agile therapeutics inc (AGRX) Snapshot

Open
$9.86
Previous Close
$9.85
Day High
$9.86
Day Low
$9.52
52 Week High
04/16/15 - $13.19
52 Week Low
11/19/14 - $5.77
Market Cap
216.1M
Average Volume 10 Days
63.2K
EPS TTM
$-1.54
Shares Outstanding
22.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AGILE THERAPEUTICS INC (AGRX)

Related News

No related news articles were found.

agile therapeutics inc (AGRX) Related Businessweek News

No Related Businessweek News Found

agile therapeutics inc (AGRX) Details

Agile Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of prescription contraceptive products for women. Its lead product candidate is Twirla, a once-weekly contraceptive patch, which is in Phase III clinical development. The company is also developing a pipeline of other new transdermal contraceptive products, including AG200-ER, a regimen that allows a woman to extend the length of her cycle; AG200-SP, a 28-day regimen, which provides a shortened hormone-free interval; and AG890, a progestin-only contraceptive patch for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was founded in 1997 and is headquartered in Princeton, New Jersey.

14 Employees
Last Reported Date: 05/12/15
Founded in 1997

agile therapeutics inc (AGRX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $522.5K
Chief Financial Officer and Vice President
Total Annual Compensation: $326.3K
Chief Medical Officer and Senior Vice Preside...
Total Annual Compensation: $424.0K
Compensation as of Fiscal Year 2014.

agile therapeutics inc (AGRX) Key Developments

Agile Therapeutics, Inc.(NasdaqGM:AGRX) added to Russell 2000 Index

Agile Therapeutics, Inc. will be added to Russell 2000 Index

Agile Therapeutics, Inc.(NasdaqGM:AGRX) added to Russell 3000 Index

Agile Therapeutics, Inc. will be added to the Russell 3000 Index.

Agile Therapeutics Seeks Acquisitions

Agile Therapeutics, Inc. (NasdaqGM:AGRX) has filed a Shelf Registration in the amount of $150.00 million, Agile will use the proceeds to pay off outstanding indebtedness, if any, and/or acquire or invest in businesses, products and technologies.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGRX:US $9.72 USD -0.13

AGRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AGRX.
View Industry Companies
 

Industry Analysis

AGRX

Industry Average

Valuation AGRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 4.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILE THERAPEUTICS INC, please visit www.agiletherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.